Orthopedic Disorder Surge Fuels Oxycodone Market Growth Driving Market Acceleration in the Oxycodone Drugs Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Oxycodone Drugs Market Size By 2025?
The market for oxycodone drugs has seen a substantial expansion in recent years. Its market size is set to rise from $5.62 billion in 2024 to $5.98 billion in 2025, marking a compound annual growth rate (CAGR) of 6.4%. This growth during the historic times can be traced back to an intense marketing campaign for oxycontin, which was promoted for chronic non-malignant discomfort and cancer. As a result, the prescription of oxycontin for non-cancer-related pain surged, thereby increasing the demand for these drugs. In addition, after World War II, synthetic opiates like oxycodone began to become more prevalent in the market.

How Big Is the Oxycodone Drugs Market Size Expected to Grow by 2029?
The market for oxycodone drugs is predicted to experience robust expansion in the upcoming years, potentially reaching $7.66 billion in 2029 with a compound annual growth rate (CAGR) of 6.4%. This expected growth during the forecast period can largely be attributed to the escalating prevalence of chronic pain, an increasing number of surgeries undertaken, strides in product development and an aging global demographic contending with increased instances of chronic pain. Key trends for the forecast period encompass a rise in the demand for abuse-deterrent formulations (ADFS), novel delivery system development, the escalating use of combined therapies, and advances in drug manufacturing technology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Which Key Market Drivers Powering Oxycodone Drugs Market Expansion and Growth?
The increasing prevalence of orthopedic disorders is predicted to boost the oxycodone drug market's expansion. Orthopedic conditions encompass a variety of musculoskeletal issues, involving bones, joints, ligaments, tendons, and muscles. These conditions cause pain, decreased mobility, and functional impairments. The growing occurrence of such disorders can be traced back to factors like aging populations, lack of physical activity, obesity, sporting injuries, and work-related risks. Oxycodone medications are employed in treating orthopedic ailments to relieve acute and chronic pain following fractures, joint traumas, or surgical discomfort. These drugs provide effective relief by targeting the pain receptors in the central nervous system. According to a forecast in October 2023 by the Institute for Health Metrics and Evaluation, a research institute in the US, the expected number of musculoskeletal disorders (orthopedic disorders) is predicted to surge by 115% (ranging between 107-124%) from 2020 to 2050, leading to an estimated 1,060 million prevalent cases by 2050. Hence, the increasing prevalence of orthopedic disorders is fueling the oxycodone drug market's expansion.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Oxycodone Drugs Market?
Leading organizations in the oxycodone drug market are making strides in creating groundbreaking medicines, such as oxycodone immediate-release (IR) tablets, aimed at minimising drug misuse through injection and intranasal administration. Oxycodone immediate-release (IR) tablets - a recipe of the opioid painkiller medication oxycodone - are engineered to provide fast pain mitigation. For example, in July 2022, the US-based firm Protega Pharmaceuticals LLC introduced RoxyBond (oxycodone) immediate-release (IR) tablets in the United States. The U.S. Food and Drug Administration (FDA) has approved RoxyBond as an opioid agonist for treating severe pain when other therapeutic alternatives aren't sufficient. The drug has been designed using sophisticated technology to prevent misuse and abuse, making it resistant to physical or chemical alterations.

What Are the Emerging Segments in the Oxycodone Drugs Market?
The oxycodone drugs market covered in this report is segmented -

1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone
2) By Dosage Form: Tablets, Capsules, Injections
3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution
2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15886&type=smp

Who Are the Global Leaders in the Oxycodone Drugs Market?
Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

Which are the Top Profitable Regional Markets for the Oxycodone Drugs Industry?
North America was the largest region in the oxycodone drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15886

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.